We are live on ! Find out more
IDXX icon

Idexx Laboratories

377 hedge funds and large institutions have $6.81B invested in Idexx Laboratories in 2016 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 114 increasing their positions, 134 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 22

10% more funds holding in top 10

Funds holding in top 10: 1011 (+1)

7% more funds holding

Funds holding: 351377 (+26)

4% more capital invested

Capital invested by funds: $6.56B → $6.81B (+$252M)

15% less repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 134

86% less call options, than puts

Call options by funds: $2.98M | Put options by funds: $20.6M

Holders
377
Holders Change
+26
Holders Change %
+7.41%
% of All Funds
10.01%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.29%
New
50
Increased
114
Reduced
134
Closed
22
Calls
$2.98M
Puts
$20.6M
Net Calls
-$17.7M
Net Calls Change
-$15.8M

IDXX Hedge Fund Activity: Q1 2016 in Review

377 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q1 2016, worth a combined $6.81B — up 3.8% from $6.56B a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new IDXX positions and 22 closed out — a net gain of 28 holders — while 114 added to existing stakes and 134 trimmed.

The largest buyer was Fundsmith LLP, adding an estimated $124M. The largest seller was T. Rowe Price Associates, cutting an estimated $246M.

  • 377 institutional investors held Idexx Laboratories (IDXX) as of Q1 2016, up from 351 in Q4 2015.
  • Funds reported $6.81B of Idexx Laboratories stock for Q1 2016, up 3.8% quarter-over-quarter.
  • 50 funds opened new Idexx Laboratories positions in Q1 2016 and 22 closed out, a net change of +28 holders.
  • The largest Idexx Laboratories buyer in Q1 2016 was Fundsmith LLP, an estimated $124M added.
  • The largest Idexx Laboratories seller in Q1 2016 was T. Rowe Price Associates, an estimated $246M sold.

Based on aggregated 13F filings for Q1 2016.